Arkolith/Insider Trading/OMIC/Form 4

Spaventa Andrew

Chief Executive Officer, DirectorSingular Genomics Systems, Inc. (OMIC) · full profile →Form 4 · filed Feb 14, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$16K
Net Open-Market Flow
-$16K
Transactions
5
4 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 14, 2025Gift(G)1K—$0143K
Feb 14, 2025Gift(G)1K—$0325
Feb 14, 2025Sell(S)800$19.89$16K1K
Feb 12, 2025Option exercise(M)2K——2K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 12, 2025Option exercise(M)2K—$023K

Transaction Codes

G
Gift
S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-021402) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML